DB14638ApprovedSmall molecule
Diloxanide is used alone as a primary agent in the treatment of asymptomatic (cyst passers) intestinal amebiasis caused by Entamoeba histolytica. Diloxanide may also be used concurrently, or sequentially, with...
- Mechanism
- Curator reviewed
Unknown. Diloxanide may inhibit protein synthesis.
- Primary indication
- Diloxanide is used alone as a primary agent in the treatment of asymptomatic (cyst passers) intestinal amebiasis caused by Entamoeba histolytica.Curator reviewed
- Formula / weight
- C14H11Cl2NO4 · 328.147 g/mol (avg)
- Also known as
- Dichlofurazol
Resolves to
Clinical / RWD
Structure
InChIKey
BDYYDXJSHYEDGB-UHFFFAOYSA-NSMILESCN(C(=O)C(Cl)Cl)C1=CC=C(OC(=O)C2=CC=CO2)C=C1What you can answer from here — as of February 21, 2021
Which companies are running trials of Diloxanide furoate, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account